ADDvise Group AB

Equities

ADDV A

SE0001306119

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:07:48 2024-05-02 am EDT			5-day change	1st Jan Change
13.9 ^SEK	+1.46%		+4.12%	-19.88%

02:00pm	Addvise Group AB Announces Chief Executive Officer Changes	CI
Apr. 18	ADDvise Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

ADDvise receives order worth EUR 2.1 million

January 16, 2024 at 01:31 am EST

ADDvise Group's subsidiary Labplan has received an order from the pharmaceutical company Eli Lilly.

The order is worth approximately EUR 2.1 million and involves advanced laboratory instruments for quality control purposes. The instruments will be used in a new manufacturing facility for biologic pharmaceuticals in Limerick, Ireland. Delivery of the order is scheduled to the fourth quarter 2024.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information

This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 16, 2024 at 07.30 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

https://news.cision.com/addvise-group-ab/r/addvise-receives-order-worth-eur-2-1-million,c3909914

https://mb.cision.com/Main/12334/3909914/2541240.pdf

Latest news about ADDvise Group AB

Addvise Group AB Announces Chief Executive Officer Changes	08:00am	CI
ADDvise Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Addvise Group AB Announces Erland Pontusson Decline Re-Election from the Board	Feb. 26	CI
ADDvise Group AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
ADDvise Group AB Receives Order Worth USD 3 Million	Dec. 29	CI
ADDvise Group AB (OM:ADDV A) cancelled the acquisition of Innovative Endoscopy Components, L.L.C.	Dec. 21	CI
ADDvise Group AB (OM:ADDV A) acquired Labplan Limited for ?20.5 million.	Dec. 21	CI
ADDvise Group AB (OM:ADDV A) acquired Axelerist, Inc. for $29.4 million.	Nov. 21	CI
Addvise Group Successfully Issues Subsequent Senior Secured Bonds of SEK 450 Million	23-10-30	CI
ADDvise Group AB Announces Nomination Committee Appointments	23-10-27	CI
ADDvise Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
ADDvise Group AB (OM:ADDV A) cancelled the acquisition of X-Ray Cassette Repair Company, Inc.	23-09-30	CI
ADDvise Group AB (OM:ADDV A) completed the acquisition of Kolplast CI S.A.	23-09-29	CI
ADDvise Group AB(OM:ADDV B) added to S&P Global BMI Index	23-09-18	CI
ADDvise Group AB (OM : ADDV A) completed the acquisition of Diabetic Supply Inc.	23-08-06	CI
Addvise Group AB's Subsidiary MRC Systems FZE Receives an Order from Tecnimont	23-08-01	CI
ADDvise Group AB Announces Management Changes	23-07-24	CI
Addvise Group AB Appoints Oliver Humlen as Member of the Executive Management Team, Effective September 18, 2023	23-07-24	CI
Certain Shares of ADDvise Group AB are subject to a Lock-Up Agreement Ending on 24-JUL-2023.	23-07-23	CI
ADDvise Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-20	CI
ADDvise Group AB Provides Earnings Guidance for the Year 2023	23-07-20	CI
ADDvise Group AB (OM:ADDV A) signed a Letter of Intent to acquire Innovative Endoscopy Components, L.L.C. for $11.75? million.	23-06-14	CI
Addvise Group AB Announces the Conditions for the Early Redemption of Existing Bonds 2021/2024 Have Been Fulfilled	23-05-26	CI
ADDvise Group AB Announces Early Redemption of Existing Bonds 2021/2024	23-05-12	CI
ADDvise Group AB Announces Successfully Place Senior Secured Bonds	23-05-11	CI

Chart ADDvise Group AB

Duration

Period

More charts

Company Profile

ADDvise Group AB, formerly ADDvise Lab Solutions publ AB, is a Sweden-based company principally engaged in the supply of fittings, equipment and safety ventilation for laboratory environments. The Companyâs service range also includes the delivery, installation, furnishing and validation of clean rooms. The Companyâs operations are divided into two business areas, namely ADDvise KEBO and ADDvise Tillquist. The ADDvise KEBO area focuses on the furnishings and protective ventilation. The ADDvise Tillquist area focuses on laboratory equipment, supplies and wave technologies. Additionally, it operates under such brand names, as ADDvise, KEBO Inredningar and Tillquist. As of December 31, 2011, it had three wholly owned subsidiaries, such as KEBO Inredningar Sverige AB, ADDvise Tillquist AB and addVise internordic AB, as well as held 50% shares of advise Ltd.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-02 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for ADDvise Group AB

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ADDVISE GROUP AB	-19.88%	148M
ABBOTT LABORATORIES	-3.71%	184B
MEDTRONIC PLC	-2.13%	107B
BECTON, DICKINSON AND COMPANY	-4.81%	67.52B
DEXCOM, INC.	+0.99%	50.06B
CENCORA, INC.	+10.07%	45.67B
HOYA CORPORATION	+3.40%	41B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.64%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	+3.86%	26.47B
TERUMO CORPORATION	+15.23%	25.05B

Other Medical Equipment, Supplies & Distribution